Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00336284 · ClinicalTrials.gov registry record · Phase 4
TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up
A Phase 4 study of Patient Indicated for an ICD, sponsored by Biotronik.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,450
- Enrollment target
- 20
- Study locations
NCT00336284 is a Phase 4 study of Patient Indicated for an ICD that has completed, run by Biotronik. The registered enrollment target is 1,450 participants. The trial reports 20 study locations across 4 states.
The verdict
NCT00336284, a Phase 4 study of Patient Indicated for an ICD, has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,450 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is a multi-center, prospective and randomized trial. The primary objective of this study is to demonstrate that the use of the BIOTRONIK Home Monitoring system (HM) can safely reduce the number of regularly scheduled office follow-up visits, compared to the conventional method of implantable cardioverter defibrillator (ICD) follow-up.
Conditions Studied
Interventions
- OTHER Home Monitoring
- OTHER In-Office Conventional Follow-up
Study Locations (20)
California
- Site 118 - Bakersfield
- Site 91 - Bakersfield
- Site 95 - Burbank
- Site 72 - Fairfield
- Site 43 - Fremont
- Site 90 - Fresno
- Site 73 - Fresno
- Site 75 - Fresno
- Site 67 - Glendale
- Site 82 - Jackson
- Site 78 - Mission Viejo
- Site 15 - Sherman Oaks
- Site 89 - Simi Valley
- Site 88 - Whittier
Colorado
- Site 37 - Boulder
- Site 38 - Boulder
- Site 98 - Denver
Arizona
- Site 68 - Mesa
- Site 99 - Phoenix
Alabama
- Site 55 - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,450 participants |
| Start Date | 2005-11 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00336284
The ClinicalTrials.gov registry entry for NCT00336284 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patient Indicated for an ICD appearing as the primary indexed condition, and to 2 interventions - of which Home Monitoring is the first listed.
NCT00336284 reports 20 study locations spanning 4 distinct geographic areas - top geographies include California, Colorado, Arizona.
Frequently Asked Questions
What is clinical trial NCT00336284 about?
NCT00336284 is a clinical study titled "TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up". This study is a multi-center, prospective and randomized trial. The primary objective of this study is to demonstrate that the use of the BIOTRONIK Home Monitoring system (HM) can safely reduce the number of regularly scheduled office follow-up visits, compared to the conventional method of implanta...
What is the current status of trial NCT00336284?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,450 participants. The study started on 2005-11. Estimated completion is 2009-06.
What conditions does trial NCT00336284 study?
This clinical trial studies the following conditions: Patient Indicated for an ICD.
What interventions are being tested in trial NCT00336284?
The interventions under investigation include: Home Monitoring (OTHER), In-Office Conventional Follow-up (OTHER).
Who is sponsoring clinical trial NCT00336284?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00336284 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.